N-(4-iodophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

ID: ALA3632736

Chembl Id: CHEMBL3632736

PubChem CID: 879999

Max Phase: Preclinical

Molecular Formula: C11H8IN5

Molecular Weight: 337.12

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Ic1ccc(Nc2ncnc3[nH]ncc23)cc1

Standard InChI:  InChI=1S/C11H8IN5/c12-7-1-3-8(4-2-7)16-10-9-5-15-17-11(9)14-6-13-10/h1-6H,(H2,13,14,15,16,17)

Standard InChI Key:  QSDMHOAEIDKWQL-UHFFFAOYSA-N

Alternative Forms

Associated Targets(Human)

MKNK2 Tchem MAP kinase signal-integrating kinase 2 (3518 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK2 Tchem Cyclin-dependent kinase 2/cyclin A (2220 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCNT1 Tchem CDK9/cyclin T1 (2643 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MV4-11 (7307 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 337.12Molecular Weight (Monoisotopic): 336.9824AlogP: 2.70#Rotatable Bonds: 2
Polar Surface Area: 66.49Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.03CX Basic pKa: 2.96CX LogP: 2.70CX LogD: 2.69
Aromatic Rings: 3Heavy Atoms: 17QED Weighted: 0.71Np Likeness Score: -2.20

References

1. Teo T, Yang Y, Yu M, Basnet SK, Gillam T, Hou J, Schmid RM, Kumarasiri M, Diab S, Albrecht H, Sykes MJ, Wang S..  (2015)  An integrated approach for discovery of highly potent and selective Mnk inhibitors: Screening, synthesis and SAR analysis.,  103  [PMID:26408454] [10.1016/j.ejmech.2015.09.008]

Source